24 extractive question-and-answer pairs built from Postpartum Haemorrhage, published by icmr.gov.in. Every answer is a verbatim span of text the source prints, and each row carries the passage it sits in, its offset in that passage, the source quote, the page and the location in the document, so any row can be checked against the original. 3 of the 24 pairs (12.5%) are explanatory questions and 21 restate a figure. 95.83% of rows pass the corpus quality gate.
Use the API URL with your free DD token in notebooks, scripts, and pipelines.
https://www.desidata.in/api/datasets/postpartum-haemorrhage-question-and-answer-dataset/downloadDataset downloads are free. For Python or API downloads, sign in once and create a free DD token; set it as DD_TOKEN or save it in your notebook's secrets. Requests are linked to your account so your download history and counts stay accurate.
# One-time install: pip install desidata
# Set DD_TOKEN in your environment first (create a free token in Profile & settings).
import desidata
df = desidata.load("postpartum-haemorrhage-question-and-answer-dataset")
df.head()Sign in with Google to download.
Usable for analysis, but expect some cleaning before you rely on it.
Consensus Document on Management of Pancreatic Cancer - Question and Answer Dataset
Economy · 268 rows
ICMR Standard Treatment Workflow for Cataract - Question and Answer Dataset
Economy · 27 rows
Neurology Questions from P a R T N E R S - Question and Answer Dataset
Economy · 107 rows
Beginner's Guide for Systematic Reviews - Question and Answer Dataset
Economy · 407 rows
Annual Report 2015-16 by agriwelfare.gov.in - Question and Answer Dataset
Economy · 1,013 rows
Higher Education in India - Question and Answer Dataset
Economy · 1,594 rows
Gender Policy of NABARD - Question and Answer Dataset
Economy · 14 rows
ICAR Annual Report 2025-26 - Question and Answer Dataset
Economy · 1,101 rows
First 10 of 25 rows
| question | answer | context | answer_start | question_type | knowledge_quality_score | source_quote | source_page | source_location | confidence | validation_status |
|---|---|---|---|---|---|---|---|---|---|---|
| What indicators are listed under the importance of timely action and referral to save a mother's life? | • PR > 120/min • Systolic BP < 100 mm Hg • Tachypnea < 95% • SpO2 < 95% • Shock index >1 (Shock index = pulse rate/systolic BP) • Deterioration of sensorium | TIMELY ACTION AND REFERRAL IS IMPORTANT TO SAVE THE LIFE OF THE MOTHER • PR > 120/min • Systolic BP < 100 mm Hg • Tachypnea < 95% • SpO2 < 95% • Shock index >1 (Shock index = pulse rate/systolic BP) • Deterioration of sensorium | 71 | list | 0.820 | • PR > 120/min • Systolic BP < 100 mm Hg • Tachypnea < 95% • SpO2 < 95% • Shock index >1 (Shock index = pulse rate/systolic BP) • Deterioration of sensorium | 1 | page=1,block=56 | 0.700 | valid |
| What should be done to evaluate vital signs during a rapid initial assessment? | PR, BP, RR and Temperature | • Call for help • Rapid Initial Assessment - evaluate vital signs: PR, BP, RR and Temperature • Establish two IV lines with wide bore cannula (16-18 gauge) • Draw blood for grouping and cross matching • Start RL/ NS, infuse 1 L in 15-20 minutes * • Give Oxygen @ 6-8 L /minute by mask, • Insert indwelling Catheter and connect to urobag • Check vitals and blood loss frequently - at least every 15 minutes • Monitor input and output • Give Inj. Oxytocin 10 IU IM (if not given after delivery) • Start Oxytocin infusion : 20 IU in 500 ml RL/NS @ 40-60 drops per minute • IV bolus of oxytocin should NOT be given • Check to see if placenta has been delivered. • Fundal Massage of the uterus • Inspect placenta for completeness • Explore uterus for any retained placental bits/ membranes/ clots and evacuate | 67 | list | 0.820 | • Call for help • Rapid Initial Assessment - evaluate vital signs: PR, BP, RR and Temperature • Establish two IV lines with wide bore cannula (16-18 gauge) • Draw blood for grouping and cross matching • Start RL/ NS, infuse 1 L in 15-20 minutes * • Give Oxygen @ 6-8 L /minute by mask, • Insert indwelling Catheter and connect to urobag • Check vitals and blood loss frequently - at least every 15 minutes • Monitor input and output • Give Inj. | ||||
| What is one of the monitoring steps listed? | Monitoring of vitals | • Monitoring of vitals • Measurement of input and output • Give blood transfusion as indicated • Check for coagulation defects • If present give blood and blood components Intra uterine balloon tamponade using condom catheter | 2 | list | 0.740 | • Monitoring of vitals • Measurement of input and output • Give blood transfusion as indicated • Check for coagulation defects • If present give blood and blood components Intra uterine balloon tamponade using condom catheter | 1 | page=1,block=6 | 0.700 | valid |
| What is the highest allowable total dose of Oxytocin within a 24-hour period? | 100 IU in 24 hours | Bleeding not controlled Bleeding not controlled Bleeding still not controlled Bleeding controlled Explore uterus for retained bits • Repeat uterine massage every 15 minutes for first two hours • Monitor vitals every 10 minutes for 30 minutes , every 15 minutes for next 30 minutes and every 30 minutes for next 3-6 hours or until stable • Continue Oxytocin infusion @5-10 units /hr (total Oxytocin not to exceed 100 IU in 24 hours) Continue bimanual compression & Oxytocin infusion @10-20 units /hr Inj Methyl Ergometrine 0.2 mg IM or IV slowly ∙ Contraindicated in hypertension, severe anemia, heart disease ∙ Can be repeated after 15 minutes to a maximum of 5 doses (1mg) Inj Carboprost (PGF2 alpha) 250 µg IM • Contraindicated in asthma • Can be repeated every 20 minutes to a maximum of 8 doses (2 mg) Tab Misoprostol (PGE1) 800 µg Per rectal or sublingual ANY OF THE FOLLOWING OPTIONS CAN BE USED EITHER ALONE OR IN COMBINATION AS PER AVAILABILITY Timely Referral to a higher centre must be considered if facilities for blood transfusion or exploration and surgical intervention are not available. | 412 | factual | 0.570 | Bleeding not controlled Bleeding not controlled Bleeding still not controlled Bleeding controlled Explore uterus for retained bits • Repeat uterine massage every 15 minutes for first two hours • Monitor vitals every 10 minutes for 30 minutes , every 15 minutes for next 30 minutes and every 30 minutes for next 3-6 hours or until stable • Continue Oxytocin infusion @5-10 units /hr (total Oxytocin not to exceed 100 IU in 24 hours) Continue bimanual compression & Oxytocin infusion @10-20 units /hr Inj Methyl Ergometrine 0.2 mg IM or IV slowly ∙ Contraindicated in hypertension, severe anemia, | ||||
| What equipment should be used during patient transport if it is available? | Non- pneumatic anti-shock garment (NASG) | Patient must be transported with I/V fluids containing oxytocin on flow and preferably with uterine/vaginal tamponade in situ. • Aortic compression may be used as a short time measure to reduce blood loss while awaiting definitive steps. • Non- pneumatic anti-shock garment (NASG) should be used during transport if available • Uterine artery embolization may be offered in selected patients if facilities are available If bleeding continues without any apparent cause check for coagulopathy | 240 | factual | 0.570 | • Non- pneumatic anti-shock garment (NASG) should be used during transport if available • Uterine artery embolization may be offered in selected patients if facilities are available If bleeding continues without any apparent cause check for coagulopathy | 1 | page=1,block=19 | 0.700 | valid |
| What is commonly recommended as an additional treatment for PPH? | Tranexamic Acid (1g slow IV) | Tranexamic Acid (1g slow IV) is routinely recommended as an adjunctive treatment for PPH to be used as early as possible irrespective of cause but definitely within three hours of delivery. It can be repeated after 30 minutes if bleeding persists Standard treatment for PPH must continue meanwhile | 0 | factual | 0.570 | Tranexamic Acid (1g slow IV) is routinely recommended as an adjunctive treatment for PPH to be used as early as possible irrespective of cause but definitely within three hours of delivery. | 1 | page=1,block=51 | 0.700 | valid |
| When should Tranexamic Acid be administered in PPH cases? | as early as possible irrespective of cause but definitely within three hours of delivery | Tranexamic Acid (1g slow IV) is routinely recommended as an adjunctive treatment for PPH to be used as early as possible irrespective of cause but definitely within three hours of delivery. It can be repeated after 30 minutes if bleeding persists Standard treatment for PPH must continue meanwhile | 100 | factual | 0.570 | Tranexamic Acid (1g slow IV) is routinely recommended as an adjunctive treatment for PPH to be used as early as possible irrespective of cause but definitely within three hours of delivery. | 1 | page=1,block=51 | 0.700 | valid |
| What is the recommended replacement ratio of crystalloid solution to blood lost during acute bleeding? | 3 ml of crystalloid solution should be used to replace every ml of blood lost | • Continue Oxytocin drip • Palpate uterus • Attempt controlled cord traction if uterus is contracted Uterus well contracted but bleeding continuing Uterus flabby • Explore for cervical/ vaginal/ perineal tears. Repair if present • If bleeding persists despite repair of above, suspect inadequate repair, rupture uterus or scar dehiscence. • Shift to OT for exploration under GA and/or laparotomy Bimanual compression and pharmacotherapy as per details below TRAUMATIC PPH ATONIC PPH * Arrange for blood / blood product at the earliest 3 ml of crystalloid solution should be used to replace every ml of blood lost during the initial part of the acute bleeding phase | 535 | factual | 0.570 | • Shift to OT for exploration under GA and/or laparotomy Bimanual compression and pharmacotherapy as per details below TRAUMATIC PPH ATONIC PPH * Arrange for blood / blood product at the earliest 3 ml of crystalloid solution should be used to replace every ml of blood lost during the initial part of the acute bleeding phase | 1 | page=1,block=10 | 0.700 | |
| What is the maximum total dose of Oxytocin allowed in 24 hours? | 100 IU in 24 hours | Bleeding not controlled Bleeding not controlled Bleeding still not controlled Bleeding controlled Explore uterus for retained bits • Repeat uterine massage every 15 minutes for first two hours • Monitor vitals every 10 minutes for 30 minutes , every 15 minutes for next 30 minutes and every 30 minutes for next 3-6 hours or until stable • Continue Oxytocin infusion @5-10 units /hr (total Oxytocin not to exceed 100 IU in 24 hours) Continue bimanual compression & Oxytocin infusion @10-20 units /hr Inj Methyl Ergometrine 0.2 mg IM or IV slowly ∙ Contraindicated in hypertension, severe anemia, heart disease ∙ Can be repeated after 15 minutes to a maximum of 5 doses (1mg) Inj Carboprost (PGF2 alpha) 250 µg IM • Contraindicated in asthma • Can be repeated every 20 minutes to a maximum of 8 doses (2 mg) Tab Misoprostol (PGE1) 800 µg Per rectal or sublingual ANY OF THE FOLLOWING OPTIONS CAN BE USED EITHER ALONE OR IN COMBINATION AS PER AVAILABILITY Timely Referral to a higher centre must be considered if facilities for blood transfusion or exploration and surgical intervention are not available. | 412 | factual | 0.570 | Bleeding not controlled Bleeding not controlled Bleeding still not controlled Bleeding controlled Explore uterus for retained bits • Repeat uterine massage every 15 minutes for first two hours • Monitor vitals every 10 minutes for 30 minutes , every 15 minutes for next 30 minutes and every 30 minutes for next 3-6 hours or until stable • Continue Oxytocin infusion @5-10 units /hr (total Oxytocin not to exceed 100 IU in 24 hours) Continue bimanual compression & Oxytocin infusion @10-20 units /hr Inj Methyl Ergometrine 0.2 mg IM or IV slowly ∙ Contraindicated in hypertension, severe anemia, | ||||
| What garment can be used during transport to manage blood loss if available? | Non- pneumatic anti-shock garment (NASG) | Patient must be transported with I/V fluids containing oxytocin on flow and preferably with uterine/vaginal tamponade in situ. • Aortic compression may be used as a short time measure to reduce blood loss while awaiting definitive steps. • Non- pneumatic anti-shock garment (NASG) should be used during transport if available • Uterine artery embolization may be offered in selected patients if facilities are available If bleeding continues without any apparent cause check for coagulopathy | 240 | factual | 0.570 | • Non- pneumatic anti-shock garment (NASG) should be used during transport if available • Uterine artery embolization may be offered in selected patients if facilities are available If bleeding continues without any apparent cause check for coagulopathy | 1 | page=1,block=19 | 0.700 | valid |
Read straight from the file — download or use the API URL for the full dataset.
| 1 |
| page=1,block=39 |
| 0.700 |
| valid |
| 1 |
| page=1,block=19 |
| 0.700 |
| valid |
| valid |
| 1 |
| page=1,block=19 |
| 0.700 |
| valid |